Biotechnology Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024 – Entera Bio (NASDAQ:ENTX) Read more
Biotechnology Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome – Entera Bio (NASDAQ:ENTX) Read more
Opinion Thinking about buying stock in Mirum Pharmaceuticals, Entera Bio, Andean Precious Metals, Viatris, or Biomx? – Mirum Pharmaceuticals (NASDAQ:MIRM), Entera Bio (NASDAQ:ENTX) Read more
Biotechnology Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement – Entera Bio (NASDAQ:ENTX) Read more
Biotechnology Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference – Entera Bio (NASDAQ:ENTX) Read more
